The FDA sent out an update on May 22 regarding drugs that are currently in shortage or are discontinued, including a recap of what was updated on May 18.
May 22, 2017
- Galantamine Tablets (New – Discontinuation)
- Glyburide Metformin Tablets (New – Discontinuation)
- Glyburide Tablets (New – Discontinuation)
- Indomethacin Capsules (New – Discontinuation)
- Disopyramide Phosphate (Norpace) Capsules (Currently in Shortage)
May 18, 2017
- Atropine Sulfate Injection (Updated – Currently in Shortage)
- Bleomycin Sulfate for Injection (Updated – Currently in Shortage)
- Calcium Chloride Injection, USP (Updated – Currently in Shortage)
- Calcium Gluconate Injection (Updated – Currently in Shortage)
- Dextrose 50% Injection (Updated – Currently in Shortage)
- Epinephrine Injection, 0.1 mg/mL (Updated – Currently in Shortage)
- L-Cysteine Hydrochloride Injection (Updated – Currently in Shortage)
- Labetalol Hydrochloride Injection (Updated – Currently in Shortage)
- Leucovorin Calcium Lyophilized Powder for Injection (Updated – Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated – Currently in Shortage)
- Methotrexate Sodium Injection (Updated – Currently in Shortage)
- Penicillin G Benzathine (Bicillin L-A) Injection (Updated – Currently in Shortage)
- Piperacillin and Tazobactam (Zosyn) Injection (Updated – Currently in Shortage)
- Potassium Phosphate Injection (Updated – Currently in Shortage)
- Sodium Acetate Injection, USP (Currently in Shortage)
- Sodium Bicarbonate Injection, USP (Updated – Currently in Shortage)
According to the FDA:
“A drug receives Resolved status when the Drug Shortages Staff (DSS) determines that the market is covered, based on information from all manufacturers. The market is considered covered when supply is available from at least one manufacturer to cover total market demand. However, some manufacturers may not have all presentations available. DSS monitors the supply of products with Resolved status. For the most current supply information, contact the manufacturers.”
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
